Dual-Task Training for People With Mild Cognitive Impairment and Mild Dementia
Launched by TAIPEI MEDICAL UNIVERSITY · Mar 30, 2024
Trial Information
Current as of May 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at a special kind of training called "dual-task training" to see if it can help improve thinking skills and other problems in older adults who have mild cognitive impairment or mild dementia. The study will last for 12 weeks, with participants attending training sessions three times a week for 45 minutes each time. There will be different groups in the study: one group will do the dual-task training, another will do cognitive training, and a third will do motor training, while a control group will receive regular care. The researchers want to find out if this dual-task training can improve overall thinking abilities, memory, sleep quality, balance, and flexibility.
To be eligible for the study, participants need to be at least 60 years old, able to communicate, and show some signs of thinking decline, but not have advanced dementia. They should not have recently participated in similar training programs or have serious issues with their vision or hearing. If someone qualifies and decides to join, they can expect to engage in fun and interactive training sessions designed to help improve their daily functioning and overall well-being. This study is not yet recruiting participants, but it aims to provide important insights into how training can support older adults facing these cognitive challenges.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Older adult \>= 60 years and able to communicate
- • CDR score range from 1 to 4
- • MMSE score \>= 18
- • Complain of conscious cognitive decline.
- • Participate voluntarily and sign informed consent.
- Exclusion Criteria:
- • Diagnosed with moderate or severe dementia.
- • Received cognitive training or motor training within six months.
- • Severe sensory function impairment (such as vision, and hearing).
- • Have limited mobility, such as those using wheelchairs or four-legged walking aids.
About Taipei Medical University
Taipei Medical University (TMU) is a leading educational and research institution located in Taipei, Taiwan, dedicated to advancing health sciences and clinical research. Established with a focus on fostering innovation in medical education, TMU integrates comprehensive clinical training with rigorous research methodologies. The university is committed to improving patient outcomes through a strong emphasis on translational medicine and interdisciplinary collaboration. TMU's clinical trial initiatives are designed to explore new treatments and therapies, contributing to the global body of medical knowledge while adhering to the highest ethical standards and regulatory compliance.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Malang, Jawa Timur, Indonesia
Patients applied
Trial Officials
Nur Aini, MSc
Principal Investigator
School of Nursing, College of Nursing, Taipei Medical University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported